Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Education Library
  3. ESMO Webinars
  4. ESMO Deep Dive: Lower Digestive Cancers - Webinar Series

ESMO Deep Dive: Lower Digestive Cancers - Insights from Biology and Clinical Research in the Management of Patients with Molecularly-Defined Subgroups of Metastatic Colorectal Cancers 2023

Aired live on 10 May 2023

ESMO-Deep-Dive-Lower-Digestive-Webinars-Metastatic-1000x250

ESMO Deep Dive: Lower Digestive Cancers - Insights from Biology and Clinical Research in the Management of Patients with Molecularly-Defined Subgroups of Metastatic Colorectal Cancers

Chair: Clara Montagut
Speakers: Andrea Sartore-Bianchi, Julien Taieb, Dominik Paul Modest, Elena Élez

(Reserved to ESMO Members)
ESMO-Deep-Dive-Lower-Digestive-Webinars-Metastatic-1000x250

This content is for ESMO members only.

Login

Learn more about how you can join ESMO

Learning objectives:

  • To acquire a deeper understanding of the clinical course of malignant disease of the lower digestive system ​
  • To understand biological hypotheses on classification and risk stratification, ongoing/required research in therapeutics and knowledge of use of omics technologies for biomarker-enabled precision medicine for Lower Digestive Cancers ​
  • To develop skills and abilities for critical analysis, interpretation of research data and therapeutic strategies ​
  • To become better equipped for informed, innovative thinking and engagement in ongoing or new research projects

Supported by

SB-Servier

The following partners supported this activity with an educational grant

SB-GSK
SB-MSD

Programme

  • Welcome and Introduction, Clara Montagut
  • Patients with mCRC bearing HER2 molecular aberrations, Andrea Sartore-Bianchi
  • Patients with mCRC bearing BRAF mutations, Julien Taieb
  • Patients with mCRC bearing RAS G12C, G12D and G12V mutations, Dominik Paul Modest
  • Patients with mCRC bearing rare molecular aberrations: ALK, ROS, NTRK, NRG1, PolE-PolD, Elena Élez
  • LIVE Q&A, All

Related Links

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.